Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research …arneurodegeneration.biomedcentral.com/articles/10.11…

Scientists have created the first map of mitochondria throughout the entire brain go.nature.com/4lnzqyX

Citrulline deficiency as a driver of aging and citrulline supplementation as a promising therapeutic intervention to counteract aging-related changes. science.org/doi/10.1126/sc…

I am excited to present our new study out in Nature Medicine where we discover a novel synaptic protein biomarker to predict if and when someone will get Alzheimer’s disease dementia. Part 2/3 from my PhD work in the Tony Wyss-Coray lab. 🧵1/12 Full study 🔗: nature.com/articles/s4159…

Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas: Neuron cell.com/neuron/fulltex…

I loved this essay on scientific writing in Nature Biotechnology (rdcu.be/edUCp). It highlights a key lesson I’ve applied throughout my career: the power of reading, thinking, and keeping a notebook with your ideas. Let me explain why this matters… 🧵👇

Thank you for joining #ADPD2025 in Vienna! It was amazing to connect with peers and experts. Let’s remain committed to improve the future for all those affected by Alzheimer's Disease. See you in 2026! #AlzheimersAwareness #ADPD40Years

Proud to share our latest Cell paper. We present a novel immune population termed PNS microglia that regulate neuronal soma size throughout evolution. cell.com/cell/abstract/… #Microglia#PNS#NeuronalSomaSize#Macrophage#BodySize#Neuroimmunology#Evolution (1/8)

Most apps for academic research require paid subscriptions. Here are 10 that are free:

If you want to understand how cells function, you have to work out what proteins interact with — and where go.nature.com/4johhzp

Microglia Reprogrammed to Deliver Precision Alzheimer’s Therapies - neurosciencenews.com/microglia-alzh… via @neurosciencenew

This is Demis Hassabis. He’s Google's DeepMind CEO, who’s studied AI for 30+ years. In his new interview with 60 Minutes, he revealed mind-blowing facts about health & AI that 99% of people wouldn’t know. Here are my top 8 takeaways: 🧵 (No. 6 will shock you)

Psychedelics can be used to target neuroimmune interactions relevant to neuropsychiatric disorders and potentially other inflammatory diseases nature.com/articles/s4158…

In ApoE4 carriers, checkpoint proteins lock microglia into a torpor. Checkpoint inhibitors release and spur them into action. Can they treat Alzheimer’s? @adpd2025 Brigham and Women's Hospital ow.ly/Z53B50VOavB

Turning off the kinase PERK in mouse astrocytes helped clear amyloid and tau from the brain and improved learning and memory. Columbia University MassGeneral News ow.ly/ZVwJ50W4vSg

Absolutely insane amount of data in this resource from Chris Mason The Spatial Atlas of Human Anatomy (SAHA): A Multimodal Subcellular-Resolution Reference Across Human Organs biorxiv.org/content/10.110… Spatial data on 15million cells from 100 donors across multiple ages, mainly GI

Stanford paid 35,000 people to quit social media. This was the largest study on emotional health in history. The results were so shocking, scientists called it "comparable to therapy." Here's what happens when you break free from the algorithm: 🧵

Temporal regulation of human reactive astrocytes reveals their capacity for antigen presentation 😍biorxiv.org/content/10.110…

Largest-ever tau-PET studies confirm ties between tangles and cognitive decline. ApoE4 carriers and women get tangles earliest. Michael Schöll Alexis Moscoso Rial Amsterdam UMC ow.ly/k8O750WqRix

Why would anyone want to be a scientist? There are the pleasures of: 1. Having the initial idea or insight, 2. Watching the idea develop into new experiments or a new model, and 3. Telling others. Martin A. Schwartz also talks about this on the podcast: podcasts.apple.com/us/podcast/74-…